Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Prostate cancer

  • You have access
    Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events
    MICHIE KATSUTA, TAKAHIRO KIMURA, KOJIRO TASHIRO, MASAYA MURAKAMI, KENICHI HATA, TAKAFUMI YANAGISAWA, HAJIME ONUMA, TOSHIHIRO YAMAMOTO, SHINGO SUGAYA, YOSHINORI WATANABE, YOSHIMASA NOBEYAMA, SHIN EGAWA and AKIHIKO ASAHINA
    Anticancer Research April 2022, 42 (4) 2023-2028; DOI: https://doi.org/10.21873/anticanres.15682
  • You have access
    Treatment Outcomes in Neuroendocrine Prostate Cancer
    HIROAKI IWAMOTO, RYUNOSUKE NAKAGAWA, TOMOYUKI MAKINO, SUGURU KADOMOTO, HIROSHI YAEGASHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research April 2022, 42 (4) 2167-2176; DOI: https://doi.org/10.21873/anticanres.15699
  • You have access
    Should 68Ga-PSMA PET/CT Replace CT and Bone Scan in Clinical Staging of High-risk Prostate Cancer?
    PIETRO PEPE and MICHELE PENNISI
    Anticancer Research March 2022, 42 (3) 1495-1498; DOI: https://doi.org/10.21873/anticanres.15621
  • You have access
    Kindlin-3 in Immune Cells Is Required to Suppress Prostate Cancer Tumor Growth in Mice
    CHENG LIU, YING ZHOU, YU ZHOU, ZHEN XU and YAN-QING MA
    Anticancer Research March 2022, 42 (3) 1217-1220; DOI: https://doi.org/10.21873/anticanres.15588
  • You have access
    Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer
    YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO
    Anticancer Research February 2022, 42 (2) 1107-1114; DOI: https://doi.org/10.21873/anticanres.15573
  • You have access
    The Role of Fast and Deep PSA Response in Castration-sensitive Prostate Cancer
    ROBERTO IACOVELLI, CHIARA CICCARESE, ORAZIO CAFFO, UGO DE GIORGI, UMBERTO BASSO, MARCELLO TUCCI, CLAUDIA MOSILLO, MARCO MARUZZO, FRANCESCA MAINES, CHIARA CASADEI, MICHELE MILELLA and GIAMPAOLO TORTORA
    Anticancer Research January 2022, 42 (1) 165-172; DOI: https://doi.org/10.21873/anticanres.15470
  • You have access
    Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study
    MIIKKA LEHTONEN, JORMA SORMUNEN, MARIE HJÄLM-ERIKSSON, CAMILLA THELLENBERG-KARLSSON, TEPPO HUTTUNEN, CLAES GINMAN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and On Behalf of the Investigators of the Scandinavian Prostate Cancer Group Study No 13
    Anticancer Research January 2022, 42 (1) 87-92; DOI: https://doi.org/10.21873/anticanres.15460
  • You have access
    Reduction in Copper Uptake and Inhibition of Prostate Cancer Cell Proliferation by Novel Steroid-based Compounds
    FANG XIE and FANGYU PENG
    Anticancer Research December 2021, 41 (12) 5953-5958; DOI: https://doi.org/10.21873/anticanres.15414
  • You have access
    Inhibition of CYP27B1 and CYP24 Increases the Anti-proliferative Effects of 25-Hydroxyvitamin D3 in LNCaP Cells
    SANDRA KARLSSON, MARIA ARACELI DIAZ CRUZ, MARIA FARESJÖ, ATHANASIA PAPADOPOULOU KHAMOU and DENNIS LARSSON
    Anticancer Research October 2021, 41 (10) 4733-4740; DOI: https://doi.org/10.21873/anticanres.15288
  • You have access
    Kartogenin Inhibits Prostate Cancer Cell Growth Through Smad2 Activation and Decreases Androgen Receptor Nuclear Localization
    MANABU TAKAI, KYOJIRO KAWAKAMI, YASUNORI FUJITA, TAKU KATO, DAIKI KATO, KOJI IINUMA, TAKUYA KOIE, MASAFUMI ITO and KOSUKE MIZUTANI
    Anticancer Research October 2021, 41 (10) 4753-4759; DOI: https://doi.org/10.21873/anticanres.15290

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 26
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire